Becker JC, Gesierich AH, Leiter U, Zimmer L, et al. Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trial. Br J Dermatol 2025 Jul 26:ljaf303. doi: 10.1093.
PMID: 40713865